Related Experiment Video
Updated: May 5, 2026
In Vivo Quantification of Protein Turnover in Aging C. Elegans using Photoconvertible Dendra2
Published on: June 13, 2020
Evaluating polyglutamine protein aggregation and toxicity in transgenic Caenorhabditis elegans models of Huntington's
Larissa Marafiga Cordeiro1, Félix Alexandre Antunes Soares1, Leticia Priscilla Arantes2
1Federal University of Santa Maria, Center for Natural and Exact Sciences, Department of Biochemistry and Molecular Biology, Graduate Program in Biological Sciences: Toxicological Biochemistry, Camobi, Santa Maria, RS, Brazil.
Insights
Huntington's disease (HD) research utilizes Caenorhabditis elegans models to study mutant huntingtin protein aggregation and toxicity. This approach helps identify potential therapeutic targets for this neurodegenerative disorder.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Huntington's disease (HD) is an inherited neurodegenerative disorder caused by CAG trinucleotide repeats in the huntingtin gene (HTT).
- This genetic defect leads to mutant huntingtin (mHTT) protein with an expanded polyglutamine (polyQ) tract, causing neuronal dysfunction and cell loss.
- Current HD treatments are symptomatic, and its pathogenesis is not fully understood.
Purpose of the Study:
- To describe experimental methods for assessing polyQ aggregation and toxicity in transgenic Caenorhabditis elegans (C. elegans) models of HD.
- To leverage C. elegans as a model organism for investigating HD mechanisms and potential therapeutic strategies.
Main Methods:
- Utilizing transgenic C. elegans strains expressing mutant huntingtin protein.
- Employing fluorescent markers to visualize and quantify polyQ aggregation and neuronal degeneration.
- Conducting behavioral assays, including thrash frequency, nose touch response, and octanol response, to assess HD-related phenotypes.
Main Results:
- The study outlines established experimental protocols for analyzing HD models in C. elegans.
- Fluorescent markers and behavioral assays effectively detect and measure polyQ aggregation and toxicity.
- These methods facilitate the study of molecular and cellular mechanisms of HD pathogenesis.
Conclusions:
- Caenorhabditis elegans provides a valuable platform for studying Huntington's disease.
- The described experimental approaches are crucial for understanding HD pathogenesis and evaluating therapeutic interventions.
- Further research using these C. elegans models can advance the development of treatments for HD.
Abstract:
Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder characterized by a repeat of the cytosine-adenine-guanine trinucleotide (CAG) in the huntingtin gene (HTT). This results in the translation of a mutant huntingtin (mHTT) protein with an abnormally long polyglutamine (polyQ) repeat. The pathology of HD leads to neuronal cell loss, motor abnormalities, and dementia. Currently, the pathogenesis of HD remains incompletely understood, and available treatments only address symptoms. Caenorhabditis elegans has been used as a model for neurodegenerative diseases, enabling the exploration of the molecular, cellular, and physiological mechanisms underlying HD pathogenesis. It also facilitates the investigation of potential therapeutic targets and interventions. Here, we describe common experiments employed to assess polyQ aggregation and toxicity in transgenic C. elegans models of HD, utilizing fluorescent markers to detect protein aggregation and neuron degeneration, in addition to specific behavioral assays (thrash frequency, nose touch response, and octanol response).
More Related Videos
08:16Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity
Published on: September 21, 2021
06:49Monitoring Protein Aggregation Kinetics In Vivo using Automated Inclusion Counting in Caenorhabditis elegans
Published on: December 17, 2021
